News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
722,347 Results
Type
Article (40999)
Company Profile (267)
Press Release (681070)
Multimedia
Podcasts (82)
Webinars (17)
Section
Business (204699)
Career Advice (2026)
Deals (35544)
Drug Delivery (111)
Drug Development (81392)
Employer Resources (173)
FDA (16420)
Job Trends (14947)
News (346453)
Policy (32746)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2571)
Accelerated approval (34)
Adcomms (24)
Allergies (144)
Alliances (49581)
ALS (170)
Alzheimer's disease (1677)
Antibody-drug conjugate (ADC) (314)
Approvals (16689)
Artificial intelligence (520)
Autoimmune disease (159)
Automation (42)
Bankruptcy (361)
Best Places to Work (11636)
BIOSECURE Act (20)
Biosimilars (192)
Biotechnology (174)
Bladder cancer (160)
Brain cancer (57)
Breast cancer (645)
Cancer (4857)
Cardiovascular disease (406)
Career advice (1711)
Career pathing (36)
CAR-T (283)
CDC (46)
Celiac Disease (2)
Cell therapy (749)
Cervical cancer (36)
Clinical research (69621)
Collaboration (1717)
Company closure (4)
Compensation (1172)
Complete response letters (57)
COVID-19 (2715)
CRISPR (93)
C-suite (863)
Cystic fibrosis (143)
Data (6296)
Decentralized trials (2)
Denatured (25)
Depression (135)
Diabetes (504)
Diagnostics (6719)
Digital health (49)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (255)
Drug pricing (184)
Drug shortages (28)
Duchenne muscular dystrophy (233)
Earnings (90261)
Editorial (58)
Employer branding (21)
Employer resources (152)
Events (117417)
Executive appointments (981)
FDA (19566)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1480)
Gene editing (199)
Generative AI (44)
Gene therapy (597)
GLP-1 (969)
Government (4671)
Grass and pollen (6)
Guidances (384)
Healthcare (18885)
HIV (62)
Huntington's disease (45)
IgA nephropathy (84)
Immunology and inflammation (254)
Immuno-oncology (60)
Indications (118)
Infectious disease (2991)
Inflammatory bowel disease (194)
Inflation Reduction Act (14)
Influenza (119)
Intellectual property (254)
Interviews (316)
IPO (16644)
IRA (51)
Job creations (3643)
Job search strategy (1429)
JPM (57)
Kidney cancer (16)
Labor market (86)
Layoffs (548)
Leadership (32)
Legal (7956)
Liver cancer (91)
Longevity (15)
Lung cancer (657)
Lymphoma (382)
Machine learning (42)
Management (59)
Manufacturing (808)
MASH (164)
Medical device (13779)
Medtech (13835)
Mergers & acquisitions (19975)
Metabolic disorders (1274)
Multiple sclerosis (164)
NASH (16)
Neurodegenerative disease (321)
Neuropsychiatric disorders (89)
Neuroscience (2923)
Neurotech (1)
NextGen: Class of 2026 (6522)
Non-profit (4516)
Now hiring (68)
Obesity (598)
Opinion (263)
Ovarian cancer (167)
Pain (199)
Pancreatic cancer (230)
Parkinson's disease (284)
Partnered (33)
Patents (507)
Patient recruitment (497)
Peanut (57)
People (58924)
Pharmaceutical (62)
Pharmacy benefit managers (29)
Phase 1 (21702)
Phase 2 (30639)
Phase 3 (22827)
Pipeline (5437)
Policy (288)
Postmarket research (2564)
Preclinical (9204)
Press Release (64)
Prostate cancer (240)
Psychedelics (49)
Radiopharmaceuticals (283)
Rare diseases (846)
Real estate (5955)
Recruiting (70)
Regulatory (24558)
Reports (53)
Research institute (2392)
Resumes & cover letters (352)
Rett syndrome (27)
RNA editing (16)
RSV (81)
Schizophrenia (148)
Series A (240)
Series B (191)
Service/supplier (11)
Sickle cell disease (97)
Special edition (22)
Spinal muscular atrophy (157)
Sponsored (42)
Startups (3620)
State (2)
Stomach cancer (18)
Supply chain (105)
Tariffs (84)
The Weekly (55)
Vaccines (1015)
Venture capital (89)
Weight loss (381)
Women's health (93)
Worklife (18)
Date
Today (37)
Last 7 days (564)
Last 30 days (2275)
Last 365 days (29744)
2026 (3983)
2025 (30173)
2024 (35221)
2023 (40085)
2022 (51178)
2021 (55713)
2020 (54085)
2019 (46544)
2018 (35021)
2017 (32127)
2016 (31483)
2015 (37553)
2014 (31318)
2013 (26349)
2012 (28574)
2011 (29271)
2010 (27331)
Location
Africa (736)
Alabama (84)
Alaska (7)
Arizona (311)
Arkansas (13)
Asia (39247)
Australia (6416)
California (11395)
Canada (3318)
China (1104)
Colorado (480)
Connecticut (483)
Delaware (341)
Europe (84621)
Florida (1710)
Georgia (361)
Hawaii (3)
Idaho (61)
Illinois (871)
India (69)
Indiana (527)
Iowa (22)
Japan (436)
Kansas (127)
Kentucky (40)
Louisiana (26)
Maine (72)
Maryland (1394)
Massachusetts (8153)
Michigan (327)
Minnesota (631)
Mississippi (5)
Missouri (128)
Montana (32)
Nebraska (28)
Nevada (122)
New Hampshire (79)
New Jersey (3025)
New Mexico (28)
New York (3004)
North Carolina (1466)
North Dakota (8)
Northern California (5577)
Ohio (337)
Oklahoma (21)
Oregon (41)
Pennsylvania (2303)
Puerto Rico (24)
Rhode Island (48)
South America (1108)
South Carolina (67)
South Dakota (1)
Southern California (4438)
Tennessee (177)
Texas (1755)
United States (40392)
Utah (340)
Vermont (1)
Virginia (264)
Washington D.C. (81)
Washington State (927)
West Virginia (4)
Wisconsin (111)
Wyoming (2)
722,347 Results for "grail inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
GRAIL Reports Fourth Quarter and Full Year 2025 Financial Results
February 19, 2026
·
19 min read
Press Releases
GRAIL, Inc. Announces $325.0 Million Private Placement Financing
October 21, 2025
·
5 min read
Press Releases
GRAIL Submits FDA Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test
January 30, 2026
·
8 min read
Press Releases
GRAIL to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 16, 2025
·
1 min read
Press Releases
GRAIL Reports Third Quarter 2025 Financial Results
November 13, 2025
·
19 min read
Press Releases
Samsung and GRAIL Announce Strategic Collaboration to Bring GRAIL’s Galleri® Multi-Cancer Early Detection Test to Asia
October 17, 2025
·
10 min read
Press Releases
GRAIL to Announce Third Quarter 2025 Financial Results
October 30, 2025
·
2 min read
Press Releases
GRAIL to Present at 7th Annual Wolfe Research Healthcare Conference
November 4, 2025
·
1 min read
Press Releases
GRAIL PATHFINDER 2 Results Show Galleri ® Multi-Cancer Early Detection Blood Test Increased Cancer Detection More Than Seven-Fold When Added to USPSTF A and B Recommended Screenings
October 20, 2025
·
14 min read
Press Releases
GRAIL Reports Second Quarter 2025 Financial Results
August 13, 2025
·
17 min read
1 of 72,235
Next
